Chris Vazquez - 10 Nov 2025 Form 4 Insider Report for BIODESIX INC (BDSX)

Role: Chief Accounting Officer
Signature: /s/ Robin H. Cowie as Attorney-in-Fact for Chris Vazquez
Issuer symbol: BDSX
Transactions as of: 10 Nov 2025
Net transactions value: -$99.06
Form type: 4
Filing time: 13 Nov 2025, 16:54:19 UTC
Previous filing: 14 Aug 2025
Next filing: 06 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Vazquez Chris	Chief Accounting Officer	919 WEST DILLON RD, LOUISVILLE	/s/ Robin H. Cowie as Attorney-in-Fact for Chris Vazquez	13 Nov 2025	0001980594

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDSX	Common Stock	Options Exercise		+31	+3.4%		949	10 Nov 2025	Direct	F1, F2
transaction	BDSX	Common Stock	Sale	$99.06	-13	-1.4%	$7.62	936	10 Nov 2025	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BDSX	Restricted Stock Units	Options Exercise	$0	-31	-52%	$0.000000	29	10 Nov 2025	Common Stock	31		Direct	F1, F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025.
F2	Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F3	These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
F4	These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.